Found 3355 matching trials
SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF) N/A Bevacizumab is an anti-angiogenic treatment used to treat various solid can...
Show More Location
Medical Oncology Service, University Hospital, Tours
Learn More & Join Trial
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors PHASE1 This is an investigator-initiated industry-supported phase 1 clinical trial...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer. PHASE2 At present, the treatment of non-squamous cell lung cancer is based on chem...
Show More Location
Avignon - Institut Sainte-Catherine
Learn More & Join Trial
SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC PHASE2 Immune checkpoint inhibitors have a poor effect on MSS colorectal cancer. S...
Show More Learn More & Join Trial
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer PHASE3 To explore the safety and efficacy of NALIRIFOX plus targeted therapy versu...
Show More Location
Shanghai Zhongshan Hospital
Learn More & Join Trial
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer PHASE2 The objective is to investigate the efficacy and safety of two-weekly alter...
Show More Location
Jiangsu Cancer Institute & Hospital
Learn More & Join Trial
The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting N/A Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the t...
Show More Location
Fundeni Clinical Institute
Learn More & Join Trial
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations PHASE2 This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma PHASE2 To evaluate the efficacy and safety of HAIC combined with Durvalumab, Treme...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
Bevacizumab/Doxorubicin/Radiation for Sarcoma PHASE1 The main purpose of this study is to test the safety, tolerability, maximum...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial